ArticleThe review of diabetic studies : RDS2009

Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.

Arie Gruzman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.